|
GTF2H2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.277610E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.537200E-03 |
| Normal-vs-Stage2 |
1.966640E-01 |
| Normal-vs-Stage3 |
3.108000E-02 |
| Normal-vs-Stage4 |
1.215890E-02 |
| Stage1-vs-Stage2 |
1.687570E-02 |
| Stage1-vs-Stage3 |
3.559000E-01 |
| Stage1-vs-Stage4 |
9.445000E-01 |
| Stage2-vs-Stage3 |
2.080600E-01 |
| Stage2-vs-Stage4 |
5.895900E-02 |
| Stage3-vs-Stage4 |
4.930200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.415960E-02 |
| Normal-vs-AfricanAmerican |
4.731800E-01 |
| Normal-vs-Asian |
7.601800E-04 |
| Caucasian-vs-AfricanAmerican |
3.317200E-01 |
| Caucasian-vs-Asian |
4.516300E-03 |
| AfricanAmerican-vs-Asian |
8.253700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.318200E-03 |
| Normal-vs-Female |
1.655810E-02 |
| Male-vs-Female |
4.031400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.082500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.787800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.119200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.577500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.429970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.502300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.835600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.144000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.412600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.577600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.184800E-01 |
| Classical-VS-Follicular |
9.023900E-03 |
| Classical-VS-Other |
6.716400E-01 |
| Classical-VS-Normal |
7.599400E-03 |
| Tall-VS-Follicular |
4.991900E-02 |
| Tall-VS-Other |
5.041400E-01 |
| Tall-VS-Normal |
7.955300E-03 |
| Follicular-VS-Other |
5.985600E-01 |
| Follicular-VS-Normal |
2.174200E-01 |
| Other-VS-Normal |
1.140380E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.185900E-02 |
| Normal-vs-N1 |
5.284600E-03 |
| N0-vs-N1 |
2.222400E-01 |
|
|
